On the public citation graph

HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma

https://doi.org/10.1007/s00432-021-03522-9
0 signed · 61 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1097-0142(19931001)72:7<2083::aid-cncr2820720705>3.0.co;2-1openalex-snapshot
Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer
inferredcites →https://doi.org/10.1002/gcc.22431openalex-snapshot
Targeted next‐generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance
inferredcites →https://doi.org/10.1002/jso.23456openalex-snapshot
HER2 in resected gastric cancer: Is there prognostic value?
inferredcites →https://doi.org/10.1007/s10120-012-0150-9openalex-snapshot
HER2 expression and its clinicopathological features in resectable gastric cancer
inferredcites →https://doi.org/10.1007/s10120-012-0179-9openalex-snapshot
Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment
inferredcites →https://doi.org/10.1007/s10120-014-0430-7openalex-snapshot
Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer
inferredcites →https://doi.org/10.1007/s10120-016-0650-0openalex-snapshot
Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: aberrant DNA methylation pathway
inferredcites →https://doi.org/10.1007/s10120-018-0876-0openalex-snapshot
Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/0304-419x(94)90012-4openalex-snapshot
The biology of erbB-2/nue/HER-2 and its role in cancer
inferredcites →https://doi.org/10.1016/j.ejca.2012.12.027openalex-snapshot
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
inferredcites →https://doi.org/10.1016/j.jmoldx.2016.09.010openalex-snapshot
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status
inferredcites →https://doi.org/10.1016/j.prp.2015.11.016openalex-snapshot
Interobserver reproducibility for HER2/neu immunohistochemistry: A comparison of reproducibility for the HercepTest™ and the 4B5 antibody clone
inferredcites →https://doi.org/10.1016/s0140-6736(03)13975-xopenalex-snapshot
Gastic cancer
inferredcites →https://doi.org/10.1016/s0140-6736(10)61121-xopenalex-snapshot
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(16)30354-3openalex-snapshot
Gastric cancer
inferredcites →https://doi.org/10.1038/35052073openalex-snapshot
Untangling the ErbB signalling network
inferredcites →https://doi.org/10.1038/nm1566openalex-snapshot
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
inferredcites →https://doi.org/10.1038/s41598-020-60897-4openalex-snapshot
Comparative analysis of HER2 copy number between plasma and tissue samples in gastric cancer using droplet digital PCR
inferredcites →https://doi.org/10.1038/sj.bjc.6603910openalex-snapshot
Targeting HER proteins in cancer therapy and the role of the non-target HER3
inferredcites →https://doi.org/10.1038/sj.onc.1210477openalex-snapshot
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
inferredcites →https://doi.org/10.1038/srep09289openalex-snapshot
The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer
inferredcites →https://doi.org/10.1093/ajcp/aqz031openalex-snapshot
Detection of ERBB2 Amplification by Next-Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma
inferredcites →https://doi.org/10.1093/annonc/mdy009openalex-snapshot
Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
inferredcites →https://doi.org/10.1111/his.13704openalex-snapshot
HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and within‐situhybridisation
inferredcites →https://doi.org/10.1111/j.1365-2559.2008.03028.xopenalex-snapshot
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
inferredcites →https://doi.org/10.1111/j.1365-2559.2011.04012.xopenalex-snapshot
Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma
inferredcites →https://doi.org/10.1126/science.2992089openalex-snapshot
Amplification of a Novel v- erb B-Related Gene in a Human Mammary Carcinoma
inferredcites →https://doi.org/10.1126/science.2999974openalex-snapshot
Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
inferredcites →https://doi.org/10.1128/mcb.2.2.127openalex-snapshot
Identification of the genetic locus for the structural gene and a new regulatory gene for the synthesis of repressible alkaline phosphatase in Saccharomyces cerevisiae.
inferredcites →https://doi.org/10.1186/1476-4598-13-105openalex-snapshot
Targeting of erbB3 receptor to overcome resistance in cancer treatment
inferredcites →https://doi.org/10.1186/s12885-016-2422-yopenalex-snapshot
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review
inferredcites →https://doi.org/10.1186/s12957-019-1652-2openalex-snapshot
Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma
inferredcites →https://doi.org/10.1186/s13046-017-0591-4openalex-snapshot
High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods
inferredcites →https://doi.org/10.1200/jco.2013.48.9070openalex-snapshot
Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab
inferredcites →https://doi.org/10.1245/aso.2003.05.010openalex-snapshot
Clinical Significance of the Epidermal Growth Factor Receptor and HER2 Receptor in Resectable Gastric Cancer
inferredcites →https://doi.org/10.12998/wjcc.v7.i15.1964openalex-snapshot
HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
inferredcites →https://doi.org/10.1309/ajcpe5nchwpsmr5dopenalex-snapshot
Impact of the 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing
inferredcites →https://doi.org/10.18632/oncotarget.23871openalex-snapshot
Association between PIK3CA alteration and prognosis of gastric cancer patients: a meta-analysis
inferredcites →https://doi.org/10.2147/cmar.s213247openalex-snapshot
Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance
inferredcites →https://doi.org/10.3322/caac.21492openalex-snapshot
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
inferredcites →https://doi.org/10.3322/caac.21590openalex-snapshot
Cancer statistics, 2020
inferredcites →https://doi.org/10.3332/ecancer.2019.962openalex-snapshot
Evaluation of the expression of the oncogen C-ERBB-2/HER2 in advanced gastric cancer cases from Costa Rica
inferredcites →https://doi.org/10.3748/wjg.v22.i23.5406openalex-snapshot
Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China
inferredcites →https://doi.org/10.3748/wjg.v22.i26.5879openalex-snapshot
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
inferredcites →https://doi.org/10.5754/hge11589openalex-snapshot
Hepatogastroenterology
inferredcites →https://doi.org/10.5858/arpa.2013-0604-oaopenalex-snapshot
HER2/neu Testing in Gastric Cancer by Immunohistochemistry: Assessment of Interlaboratory Variation
inferredcites →https://doi.org/10.7150/jca.19984openalex-snapshot
Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric Cancer

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4107700openalex-extracted
Impact of the HER2 Expression on Survival and Fluorouracil-Based Adjuvant Chemotherapeutic Benefits in Stage II/III Gastric Cancer: A Multicenter Observational Study
inferred← citeshttps://doi.org/10.1007/s12094-024-03410-xopenalex-snapshot
Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study
inferred← citeshttps://doi.org/10.1016/j.modpat.2022.100014openalex-snapshot
Analysis of KRAS Mutations in Gastrointestinal Tract Adenocarcinomas Reveals Site-Specific Mutational Signatures
inferred← citeshttps://doi.org/10.1038/s41698-024-00725-4openalex-snapshot
The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG
inferred← citeshttps://doi.org/10.1097/js9.0000000000000370openalex-snapshot
Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational study
inferred← citeshttps://doi.org/10.1097/md.0000000000032781openalex-snapshot
Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer
inferred← citeshttps://doi.org/10.1159/000542900openalex-snapshot
Prognostic Significance of HER2 Positivity in Endometrium Cancer
inferred← citeshttps://doi.org/10.1177/00368504251362310openalex-snapshot
A stage IV high-grade serous ovarian cancer patient carrying ERBB2 amplification and ERBB2 overexpression benefits from late-line pyrotinib treatment: A case report
inferred← citeshttps://doi.org/10.1200/po.21.00330openalex-snapshot
ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti–Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma
inferred← citeshttps://doi.org/10.1245/s10434-023-14249-xopenalex-snapshot
Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable Gastric Cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1432281openalex-snapshot
Construction of a nomogram with IrAE and clinic character to predict the survival of advanced G/GEJ adenocarcinoma patients undergoing anti-PD-1 treatment
inferred← citeshttps://doi.org/10.3389/fonc.2022.986674openalex-snapshot
Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors
inferred← citeshttps://doi.org/10.3390/cancers16162854openalex-snapshot
Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.3390/pharmaceutics14091759openalex-snapshot
Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.